IRS2 and thyroid tumor: MiR-7-5p, IRS2 and EGFR expressions are correlated with the aggressivity of thyroid tumors: more aggressive BRAFV600E positive PTC exhibit a more pronounced decrease of miR-7-5p expression and increase of IRS2 or EGFR expressions compared to BRAFV600E negative PTC.